[Skip to Navigation]
[Skip to Navigation Landing]
Views 2,584
Citations 0
Biotech Innovations
May 14, 2019

Novel Nanochip Paves Way for Early Ovarian Cancer Detection

JAMA. 2019;321(18):1759. doi:10.1001/jama.2019.5460

Currently, no ovarian cancer screening test with high sensitivity and specificity exists. In a recent proof-of-concept study published in Nature Biomedical Engineering, a uniquely designed microfluidic nanochip detected low levels of ovarian cancer–associated markers in blood. If validated in large trials, the technology could be used for early detection of the cancer, which is currently diagnosed at late clinical stages in approximately 85% of patients.